Elzbieta Janczur, MD | |
900 Canton Ave, Anesthesia Department, Baltimore, MD 21229 | |
(410) 368-3045 | |
Not Available |
Full Name | Elzbieta Janczur |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 28 Years |
Location | 900 Canton Ave, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154328839 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | D0037455 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
Medstar Union Memorial Hospital | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
Today's headlines include stories detailing the politics stirred up by GOP vice presidential candidate Paul Ryan's return to Capitol Hill, as well as reports about new poll numbers and the latest about how health issues are playing on the campaign trail.
Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.
A new study on Alzheimer's disease by Scripps Research scientists has revealed a previously unknown biochemical cascade in the brain that leads to the destruction of synapses, the connections between nerve cells that are responsible for memory and cognition.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.
› Verified 5 days ago
Entity Name | First Colonies Anesthesia Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740218767 PECOS PAC ID: 8426039744 Enrollment ID: O20040525000119 |
News Archive
Today's headlines include stories detailing the politics stirred up by GOP vice presidential candidate Paul Ryan's return to Capitol Hill, as well as reports about new poll numbers and the latest about how health issues are playing on the campaign trail.
Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.
A new study on Alzheimer's disease by Scripps Research scientists has revealed a previously unknown biochemical cascade in the brain that leads to the destruction of synapses, the connections between nerve cells that are responsible for memory and cognition.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.
› Verified 5 days ago
Entity Name | Medstar Medical Group Anesthesiology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171207001966 |
News Archive
Today's headlines include stories detailing the politics stirred up by GOP vice presidential candidate Paul Ryan's return to Capitol Hill, as well as reports about new poll numbers and the latest about how health issues are playing on the campaign trail.
Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.
A new study on Alzheimer's disease by Scripps Research scientists has revealed a previously unknown biochemical cascade in the brain that leads to the destruction of synapses, the connections between nerve cells that are responsible for memory and cognition.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Elzbieta Janczur, MD 66 Powerhouse Rd, 3rd Floor, Roslyn Heights, NY 11577-1324 Ph: (516) 626-6366 | Elzbieta Janczur, MD 900 Canton Ave, Anesthesia Department, Baltimore, MD 21229 Ph: (410) 368-3045 |
News Archive
Today's headlines include stories detailing the politics stirred up by GOP vice presidential candidate Paul Ryan's return to Capitol Hill, as well as reports about new poll numbers and the latest about how health issues are playing on the campaign trail.
Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.
A new study on Alzheimer's disease by Scripps Research scientists has revealed a previously unknown biochemical cascade in the brain that leads to the destruction of synapses, the connections between nerve cells that are responsible for memory and cognition.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.
› Verified 5 days ago
Kathryn Rosenblatt, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 410-955-7461 Fax: 410-614-7903 | |
Dr. Tiffani Danielle Pittman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5601 Loch Raven Blvd, Baltimore, MD 21239 Phone: 443-444-4863 Fax: 443-444-4997 | |
Aaron Sachs, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 22 S Greene St # S11c, University Of Maryland Department Of Anesthesia, Baltimore, MD 21201 Phone: 410-328-1239 | |
Dr. Mohamed Ehab Ramadan Mohamed Ramadan, MBBCH, MSC, PHD Anesthesiology Medicare: Medicare Enrolled Practice Location: 600 North Wolfe Street, Nelson 2-131, Baltimore, MD 21287 Phone: 410-955-1818 | |
Lynette Mark, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6353 | |
Charles Lin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Canton Ave, Baltimore, MD 21229 Phone: 410-368-3045 Fax: 410-951-4009 | |
Dr. Jasjit B Atwal, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St, Suite 300 6th Fl, Baltimore, MD 21201 Phone: 410-328-6720 Fax: 410-328-1674 |